Oroxylin A maintains the colonic mucus barrier to reduce disease susceptibility by reconstituting a dietary fiber-deprived gut microbiota

Cancer Lett. 2021 Sep 1:515:73-85. doi: 10.1016/j.canlet.2021.05.018. Epub 2021 May 28.

Abstract

Dietary fiber intake helps to maintain gut homeostasis. Fiber deficiency causes commensals to utilize mucins as an energy source to destroy mucus layer, thus promoting susceptibility to inflammatory bowel disease. Here, we reported that oroxylin A, a natural flavonoid, ameliorated low-grade colonic inflammation caused by fiber deficiency, alleviated colitis, and further prevented colitis-associated colon cancer in mice. The anti-inflammatory effect of oroxylin A was due to its alteration of gut microbiota. We found that the levels of Eubacterium coprostanoligenes was significantly increased by oroxylin A and the colonized Eubacterium coprostanoligenes significantly protected against colitis and carcinogenesis in colon of mice. Together, our results in this study suggest that oroxylin A may reduce the susceptibility to intestinal diseases by increasing the level of Eubacterium coprostanoligenes which could provide a therapeutic alternation for the treatment of intestinal diseases.

Keywords: Dietary fiber; Eubacterium coprostanoligenes; Gut microbiota; Mucus layer; Oroxylin A.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Colitis / drug therapy
  • Colon / drug effects
  • Colonic Neoplasms / drug therapy
  • Dietary Fiber
  • Disease Susceptibility
  • Female
  • Flavonoids / pharmacology*
  • Gastrointestinal Microbiome / drug effects*
  • Inflammation / drug therapy
  • Inflammatory Bowel Diseases / drug therapy
  • Intestinal Mucosa / drug effects*
  • Mice
  • Mice, Inbred C57BL

Substances

  • Dietary Fiber
  • Flavonoids
  • 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one